In the third quarter of 2023 – specifically, from July 1 to Sept. 30 – there are 43 drugs covered under Medicare Part B that will have their coinsurance rates changed based on an inflation-adjusted payment amount. This adjustment is relevant to those individuals enrolled in both traditional Medicare and Medicare Advantage, and those who will use these specific drugs.
Depending on additional health coverage held by such individuals, this adjustment may result in a reduction in the coinsurance payments for which they are responsible. The savings that beneficiaries can expect to experience are tangible, with the coinsurance amounts potentially being lower than they would have been prior to the enactment of the new law.
The range of these savings is likewise quite substantial, varying from as little as $1 to as much as $449 per average dose. This range demonstrates the potential significant financial impact the new law could have on beneficiaries’ out-of-pocket healthcare costs.
This is great until you look at the 43 drugs selected. They do not appear to be the drugs that drain the pocketbooks of the elderly. I was surprised to see the drug Humira, used to treat psoriasis, on the list, considering how heavily it has been marketed.
I was also disappointed to see Vivitrol make the list. More commonly called “Naltrexone,” Vivitrol is an opioid antagonist, meaning it blocks the pleasurable effects of drinking.
The controversy with Naltrexone and drugs like it is that they are directly contrary to the last 90 years of information from recovery programs indicating that the only solution to addiction is complete abstinence.
There are so many drugs that Medicare recipients need and can’t afford. Let’s hope Medicare picks more wisely next time.
Not having enough qualified health information management (HIM) staff is a significant global challenge that severely impacts healthcare systems. This shortage of HIM professionals leads
The Biden Administration has released a new playbook addressing three “pillars” of emphasis related to the social determinants of health (SDoH), from the Domestic Policy
Please log in to your account to comment on this article.
Unlock the keys to bridging the clinical-finance disconnect by transforming your approach to revenue cycle collaboration for superior patient care and financial prosperity!
Join Dr. Ronald Hirsch as he delves into the pivotal connection between case management, utilization review, and hospital revenue cycles, unveiling strategies to enhance communication and align goals effectively. Discover how to overcome hidden challenges hindering seamless collaboration and gain insights imperative for success
During this webcast Dr. Hirsch will breakdown the CMS-4201-F rule and the new federal regulations, how and when they will apply to Medicare Advantages plans.
The CMS Two-Midnight Rule and short-stay audits are here to stay, impacting inpatient and outpatient admissions, ASC procedures, and Medicare Parts C & D. New for 2024, the Two-Midnight Rule applies to Medicare Advantage patients, requiring differentiation between Medicare plans affecting Case Managers, Utilization Review, and operational processes and knowledge of a vital distinction between these patients that influences post-discharge medical reviews and compliance risk. Join Michael G. Calahan for a comprehensive webcast covering federal laws for all admission processes. Gain the knowledge needed to navigate audits effectively and optimize patient access points, personnel, and compliance strategies. Learn Two-Midnight Rule essentials, Medicare Advantage implications, and compliance best practices. Discover operational insights for short-stay admissions, outpatient observation, and the ever-changing Inpatient-Only Listing.
A massive task lies ahead! Now’s the time to start preparing your case management and utilization review teams for successful implementation of changes contained in the 2024 IPPS, OPPS and MPFS rules.
Uncover effective techniques to foster provider understanding of CDI, empower CDISs and coders to customize their queries for enhanced effectiveness, and learn to engage adult learners, leveraging their experiences for superior learning outcomes. Elevate your CDI expertise, leading to fewer coding errors, reduced claim denials, and minimized audit issues.
This exclusive ICD10monitor webcast series will help you acquire the critical knowledge you need to completely and accurately assign ICD-10-PCS and CPT® codes for spinal fusion and other common spinal procedures.
This exclusive ICD10monitor webcast is intended to elevate and streamline outpatient coding for spinal procedures. Our expert presenter, Kim Felix, RHIA, CCS., will provide clear, detailed explanations covering spinal anatomy, spinal procedures, and correct CPT coding practices.
During this exclusive ICD10monitor webcast, inpatient coders will gain a profound understanding of prevalent spinal procedures. They’ll delve into the intricate anatomy, grasp the purpose and method behind these procedures, uncover essential elements within physician documentation, and receive expert guidance, step by step, on constructing accurate ICD-10-PCS codes. It’s the key to enhancing their expertise and ensuring coding precision.
Copyright © 2023 ICD10monitor. Powered by MedLearn Media.
